Abstract
A variety of pancreatic and peripancreatic neoplasms may contain calcifications. We present a review of common to uncommon pancreatic neoplasms that may contain calcifications to include ductal adenocarcinoma, pancreatic neuroendocrine tumors, serous cystadenomas, solid pseudopapillary tumors, intraductal papillary mucinous neoplasms, mucinous cystic neoplasms, and lymphoepithelial cysts. In addition, duodenal mucinous adenocarcinoma can present as a peripancreatic mass that may contain calcification. Knowledge of the spectrum of calcification patterns can help the interpreting radiologist provide a meaningful differential.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
A variety of pancreatic and peripancreatic neoplasms may contain calcifications. Knowledge of what lesions may calcify and the patterns of calcifications can help the interpreting radiologist hone in on a specific diagnosis or refine a differential diagnosis which may alter management.
Common pancreatic neoplasms that may contain calcifications
Ductal adenocarcinoma
Pancreatic ductal adenocarcinoma represents the twelfth most common cancer with an incidence of 48,960 new cases in the United States and 40,560 deaths in 2015 according to the surveillance, epidemiology, and end results (SEER) Program. This accounts for 3% of all new cancer cases and 6.9% of cancer deaths. It has an abysmal 5-year survival of a mean 7.2% for all stages, 27% for localized disease, and 2.4% for metastatic disease. It is slightly more common in men with a mean age of diagnosis of 70 years. It accounts for 85% of all pancreatic neoplasms. They can be found incidentally or during workup for jaundice [1].
Up to 70% of tumors are localized to the pancreatic head, 25% to the body and tail. On CT imaging, tumors appear as a solid, hypovascular mass that frequently causes ductal obstruction. They are best seen in venous phase imaging but occasionally may become isodense during venous phase. Calcification, while uncommon, can be punctate or coarse (Fig. 1). The etiology of calcification has not been confirmed but postulated to be dystrophic, related to necrosis, in the absence of chronic pancreatitis change. The presence of calcification should not dissuade the radiologist from raising concern for adenocarcinoma, particularly in the setting of an obstructing pancreatic head mass [2]. Patients with chronic calcifying pancreatitis are at higher risk for adenocarcinoma and may develop tumor around calcifications, which can appear punctate to large clusters. In a 2017 series of 48 patients, Mohamed et al. demonstrated scarce calcifications in 22%, abundant calcifications in 44%, and very abundant calcifications in 33% of their patients with chronic calcifying pancreatitis that developed cancer as an obvious hypodense mass that displaced pancreatitis calcifications [3].
Uncommon pancreatic neoplasms that may contain calcifications
Pancreatic neuroendocrine tumors
Pancreatic neuroendocrine tumors (PNETs) account for 1–2% of all pancreatic tumors with an annual incidence of less than 1 per 100,000, typically seen in older adults [4,5,6]. Small lesions are frequently found incidentally when imaging for other reasons or present with a related hormonal syndrome. Nearly all well-differentiated PNETs have been found to produce some hormones. Most patients do not present with an endocrinopathy as the hormones are produced in small quantities and are considered non-hyperfunctioning or non-functional. When symptoms of a paraneoplastic endocrinopathy are present, the tumors are considered hyperfunctioning or functional [6, 7].
On imaging, tumors can range from small vascular masses to large heterogeneous cystic masses. They usually do not obstruct the duct as with adenocarcinoma. Larger tumors can have vascular invasion, especially into the portal, superior mesenteric, or splenic veins, unlike adenocarcinoma which typically narrows and encases vessels. Increasing tumor size has been associated with cystic necrosis and subsequent development of dystrophic calcifications [8]. Calcifications more commonly occur within non-functioning and larger neoplasms. Insulinoma represents the most common functional PNET. They are usually small at diagnosis, which may contain calcifications in up to 20% of cases. Calcifications can be found in PNETs in up to 16% of cases. Calcifications are usually focal, coarse, irregular, and centrally located [8, 9] (Figs. 2, 3).
Serous cystadenoma
Serous cystadenomas are benign cystic tumors frequently found in woman in the 5th to 7th decades. They are usually located in the pancreatic head. Small tumors are usually incidentally found. Tumors great than 4 cm are more likely to be symptomatic. Three morphologic types are seen at imaging which include polycystic (70%), honeycomb (20%), or oligocystic (10%). The polycystic variant contains cystic components less than 2 cm. Lobulations and a central scar are seen with this variant. Stellate central calcification is seen in a third of cases (Fig. 4). The etiology of formation of calcification remains unknown. Oligocystic variants contain cystic components greater than 2 cm. Oligocystic variants can mimic mucinous tumors however usually do not contain mural calcification as mucinous tumors can demonstrate. Honeycomb variant contain tiny cysts which at times can appear as a solid mass [10,11,12].
Solid pseudopapillary tumor
Solid pseudopapillary tumors (SPTs), also known as solid pseudopapillary epithelial neoplasms (SPENs), are rare pancreatic tumors, accounting for only 1%–2% of pancreatic exocrine neoplasms, occurring predominately in women in the second or third decade [13,14,15]. SPTs are typically large at diagnosis, with a report mean diameter of 9 cm. Recent studies have categorized SPTs into small (≤3 cm) and large tumors (≥3 cm) with separate imaging findings. Large SPTs are typically well demarcated, encapsulated appearing masses with peripheral solid and central cystic components. Calcifications, usually peripheral, are seen in 65% of cases (Fig. 5) [16]. Contradistinction to large SPTs, small SPTs are homogeneous, solid masses with less frequent calcification, which can mimic adenocarcinoma or PNET. Atypical SPTs may demonstrate massive dense calcification or rarely curvilinear or stippled calcification [5]. Calcifications are thought to be dystrophic following intratumoral hemorrhage or cystic change, typical of SPT [17].
Intraductal papillary mucinous neoplasm
Intraductal papillary mucinous neoplasms (IPMNs) account for up to 7% of all pancreatic neoplasms, typically in older male patients (5:1 male to female), 60 to 70 years old. They are categorized by location as branch duct, main duct, or mixed types. There are four histologic subtypes which include gastric, intestinal, pancreaticobiliary, and oncocytic where gastric and intestinal subtypes comprise the majority of subtypes [18,19,20].
IPMNs occur usually in the head and uncinate process in up to 70% of cases. On imaging, branch-duct IPMNs can appear unilocular or multilocular cystic masses, whereas main-duct types appear as main duct dilation, currently set at 5 mm or greater by international consensus guidelines. All IPMNs have some malignant potential. Malignant features or features predictive of malignancy include large size greater than 3 cm, mural nodularity and duct obstruction [21, 22].
Calcifications, typically mural, have been reported in up to 25% of IPMNs with punctate calcification seen in approximately 90% of cases. Coarse and eggshell calcifications have also been described. The presence of punctate calcification (Fig. 6) has not been associated with malignancy. However, coarse calcifications when present are highly associated with malignancy (Fig. 7). Although the exact mechanism for calcification is unknown, it is thought that thick mucin binds calcium salts [23,24,25].
Mucinous cystic neoplasm
Pancreatic mucinous cystic neoplasms (MCN) are rare tumors nearly exclusively found in women (20:1 women to men) who are 40–60 years old. Patients are usually asymptomatic or complain of vague abdominal or back pain, nausea, vomiting, or present with pancreatitis [26].
They are differentiated from other pancreatic mucin producing neoplasms such as intraductal papillary mucinous neoplasms with the presence of ovarian-type stroma. Estrogen and progesterone receptors have been demonstrated in this ovarian-type stroma which may explain the predominance in women [27].
On imaging, MCNs are nearly always found in the body or tail without ductal communication. Size can range from small to very large (2–36 cm). Septations may be seen which can create a multilocular appearance. MCNs do have malignant potential which should be suggested when the MCN is larger than 2 cm or when irregularity or nodularity of the wall and/or septation is discovered. MCNs can calcify with peripheral eggshell or focal punctate calcifications (Fig. 8) in up to 25% of cases. The mechanism of calcification is uncertain, probably dystrophic. This should also be reported as potential malignant feature [28,29,30].
Lymphoepithelial cyst
Lymphoepithelial cysts (LECs) are very rare, non-malignant, true pancreatic cysts, seen in less than 1% of pancreatic cystic neoplasms. Cysts are lined with squamous epithelium and surrounded by mature lymphoid tissue. They are frequently seen in middle age men (4–7:1 men to women) contrary to other pancreatic cystic masses which are typically seen in women [18, 31].
On imaging, LECs are appeared as exophytic masses arising near the surface of the pancreas. There is no site predilection. Sizes can range from subcentimeter to nearly to 20 cm with an average of 4.5 cm. The internal contents can be complex appearing due to the granular keratinized material within the cyst fluid. Enhancing septations are common in up to 50% of cases yielding a multilocular appearance. LECs rarely calcify but are usually peripheral punctate to coarse when found (Fig. 9). Origin of calcifications is uncertain but may be related to keratinous plugs, squamous metaplasia, or granulomas in the lymphoid tissue [32, 33].
Peripancreatic neoplasms that may contain calcifications
Duodenal adenocarcinoma
Small bowel cancers are rare tumors, comprising less than 5 percent of all gastrointestinal cancers with up to 23 cases per million persons in 2004 reported by SEER [34, 35]. Adenocarcinoma accounts for up to 40% of all small bowel cancers. Patients are usually in their sixth decade of life without sex predilection. The duodenum is the most common tumor site in up to 50% of cases followed by jejunum then ileum. The periampullary region is the most common location. The adenoma-carcinoma sequence, similar to colon cancer formation, has been observed for duodenal carcinomas. Additional risk for carcinoma increases in the presence of genetic syndromes such as familial adenomatous polyposis and Peutz-Jeghers syndrome. Celiac and Crohn’s diseases are additional risk factors with tumor forming more commonly in the jejunum and ileum, respectively. Patients are usually symptomatic with pain, weight loss, obstructive symptoms, bleeding, and rarely perforation. Mucinous subtypes exist, similar to other bowel mucinous adenocarcinoma subtypes, may contain uncommon variable punctate to coarse calcification, likely dystrophic (Fig. 10) [36, 37].
Conclusion
This review article describes the common to uncommon pancreatic and peripancreatic neoplasms that may contain calcifications (Table 1). Some neoplasms contain calcifications more frequently than others. The interpreting radiologist should not be dissuaded from an important diagnosis of adenocarcinoma if calcification is found. Knowledge of the frequency and pattern of calcification in the other uncommon neoplasms can help the radiologist hone into a specific diagnosis or refine the differential diagnosis.
References
National Cancer Institute. SEER cancer statistics factsheets: pancreas cancer. http://seer.cancer.gov/statfacts/html/pancreas.html. Accessed 11 Nov 2016.
Pietryga JA, Morgan DE (2015) Imaging preoperatively for pancreatic adenocarcinoma. J Gastrointest Oncol 6(4):343–357
Mohamed A Jr, Ayav A, Belle A, et al. (2017) Pancreatic cancer in patients with chronic calcifying pancreatitis: computed tomography findings—a retrospective analysis of 48 patients. Eur J Radiol 86:206–212
Niederle MB, Hackl M, Kaserer K, Niederle B (2010) Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters. Endocr Relat Cancer 17(4):909–918
Halfdanarson TR, Rubin J, Farnell MB, Grant CS, Petersen GM (2008) Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors. Endocr Relat Cancer 15(2):409–427
Hruban RH, Pitman MB, Klimstra DS (2007) Endocrine Neoplasms. In: Hruban RH, Pitman MB, Klimstra DS (eds) Tumors of the pancreas: AFIP atlas of tumor pathology, vol. 251, 4th edn. Washington DC: American Registry of Pathology
Metz DC, Jensen RT (2008) Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. Gastroenterology 135(5):1469–1492
Lesniak RJ, Hohenwalter MD, Taylor AJ (2002) Spectrum of causes of pancreatic calcifications. AJR Am J Roentgenol 178(1):79–86
Poultsides GA, Huang LC, Chen Y, et al. (2012) Pancreatic neuroendocrine tumors: radiographic calcifications correlate with grade and metastasis. Ann Surg Oncol 19(7):2295–2303
Sarr MG, Murr M, Smyrk TC, et al. (2003) Primary cystic neoplasms of the pancreas. Neoplastic disorders of emerging importance-current state-of-the-art and unanswered questions. J Gastrointest Surg 7(3):417–428
Curry CA, Eng J, Horton KM, et al. (2000) CT of primary cystic pancreatic neoplasms: can CT be used for patient triage and treatment? AJR Am J Roentgenol 175(1):99–103
Perez-Ordonez B, Naseem A, Lieberman PH, Klimstra DS (1996) Solid serous adenoma of the pancreas. The solid variant of serous cystadenoma? Am J Surg Pathol 20(11):1401–1405
Bosman F (2010) WHO classification of tumours of the digestive system, 4th edn. Lyon: IARC Press
Papavramidis T, Papavramidis S (2005) Solid pseudopapillary tumors of the pancreas: review of 718 patients reported in English literature. J Am Coll Surg 200(6):965–972
Lam KY, Lo CY, Fan ST (1999) Pancreatic solid-cystic-papillary tumor: clinicopathologic features in eight patients from Hong Kong and review of the literature. World J Surg 23(10):1045–1050
Buetow PC, Buck JL, Pantongrag-Brown L, et al. (1996) Solid and papillary epithelial neoplasm of the pancreas: imaging-pathologic correlation on 56 cases. Radiology 199(3):707–711
Baek JH, Lee JM, Kim SH, et al. (2010) Small (< or = 3 cm) solid pseudopapillary tumors of the pancreas at multiphasic multidetector CT. Radiology 257(1):97–106
Adsay NV, Hasteh F, Cheng JD, et al. (2002) Lymphoepithelial cysts of the pancreas: a report of 12 cases and a review of the literature. Mod Pathol 15(5):492–501
Ferrone CR, Correa-Gallego C, Warshaw AL, et al. (2009) Current trends in pancreatic cystic neoplasms. Arch Surg 144(5):448–454
Adsay V, Mino-Kenudson M, Furukawa T, et al. (2016) Pathologic evaluation and reporting of intraductal papillary mucinous neoplasms of the pancreas and other tumoral intraepithelial neoplasms of pancreatobiliary tract: recommendations of Verona Consensus Meeting. Ann Surg 263(1):162–177
Anand N, Sampath K, Wu BU (2013) Cyst features and risk of malignancy in intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis. Clin Gastroenterol Hepatol 11(8):913–921 (quiz e59–60)
Tanaka M, Fernandez-del Castillo C, Adsay V, et al. (2012) International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 12(3):183–197
Zapiach M, Yadav D, Smyrk TC, et al. (2004) Calcifying obstructive pancreatitis: a study of intraductal papillary mucinous neoplasm associated with pancreatic calcification. Clin Gastroenterol Hepatol 2(1):57–63
Kalaitzakis E, Braden B, Trivedi P, Sharifi Y, Chapman R (2009) Intraductal papillary mucinous neoplasm in chronic calcifying pancreatitis: egg or hen? World J Gastroenterol 15(10):1273–1275
Perez-Johnston R, Narin O, Mino-Kenudson M, et al. (2013) Frequency and significance of calcification in IPMN. Pancreatology 13(1):43–47
Nilsson LN, Keane MG, Shamali A, et al. (2016) Nature and management of pancreatic mucinous cystic neoplasm (MCN): a systematic review of the literature. Pancreatology 16(6):1028–1036
Goh BK, Tan YM, Kumarasinghe MP, Ooi LL (2005) Mucinous cystic tumor of the pancreas with ovarian-like mesenchymal stroma in a male patient. Dig Dis Sci 50(11):2170–2177
Zamboni G, Scarpa A, Bogina G, et al. (1999) Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors. Am J Surg Pathol 23(4):410–422
Grogan JR, Saeian K, Taylor AJ, et al. (2001) Making sense of mucin-producing pancreatic tumors. AJR Am J Roentgenol 176(4):921–929
de Lima JE, Jr Javitt MC, Mathur SC (1999) Mucinous cystic neoplasm of the pancreas. Radiographics 19(3):807–811
Kim WH, Lee JY, Park HS, et al. (2013) Lymphoepithelial cyst of the pancreas: comparison of CT findings with other pancreatic cystic lesions. Abdom Imaging 38(2):324–330
Mege D, Gregoire E, Barbier L, Del Grande J, Le Treut YP (2014) Lymphoepithelial cyst of the pancreas: an analysis of 117 patients. Pancreas 43(7):987–995
Kavuturu S, Sarwani NE, Ruggeiro FM, et al. (2013) Lymphoepithelial cysts of the pancreas. Can preoperative imaging distinguish this benign lesion from malignant or pre-malignant cystic pancreatic lesions? JOP 14(3):250–255
Neugut AI, Jacobson JS, Suh S, Mukherjee R, Arber N (1998) The epidemiology of cancer of the small bowel. Cancer Epidemiol Biomark Prev 7(3):243–251
Bilimoria KY, Bentrem DJ, Wayne JD, et al. (2009) Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg 249(1):63–71
Aparicio T, Zaanan A, Mary F, et al. (2016) Small bowel adenocarcinoma. Gastroenterol Clin North Am 45(3):447–457
Chae MJ, Baek IH, Oh YM, et al. (2015) A patient with duodenal mucinous adenocarcinoma presenting as a laterally spreading tumor. Clin Endosc 48(4):336–339
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
No funding was obtained for this study.
Conflict of Interest
The authors declare that they have no conflicts of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent waiver was obtained by institutional review board for this the study.
Rights and permissions
About this article
Cite this article
Verde, F., Fishman, E.K. Calcified pancreatic and peripancreatic neoplasms: spectrum of pathologies. Abdom Radiol 42, 2686–2697 (2017). https://doi.org/10.1007/s00261-017-1182-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-017-1182-8